Young-Hyuck Im Selected Research

Fluorouracil (Carac)

4/2009	Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC).
6/2008	A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
10/2005	Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
7/2005	Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study.
4/2005	Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young-Hyuck Im Research Topics

Disease

119	Breast Neoplasms (Breast Cancer) 12/2023 - 05/2005
50	Neoplasms (Cancer) 10/2023 - 01/2004
17	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2004
16	Triple Negative Breast Neoplasms 01/2024 - 03/2009
12	Pathologic Complete Response 10/2022 - 04/2015
11	Neutropenia 01/2020 - 01/2004
9	Disease Progression 11/2023 - 01/2012
6	Esophageal Squamous Cell Carcinoma 01/2022 - 10/2005
4	Diarrhea 01/2012 - 01/2004
3	Residual Neoplasm 10/2022 - 01/2007
3	Anemia 07/2021 - 01/2004
3	Thrombocytopenia (Thrombopenia) 01/2019 - 11/2004
3	Febrile Neutropenia 08/2017 - 01/2012
3	Stomach Neoplasms (Stomach Cancer) 02/2008 - 12/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2005 - 11/2003
2	Exanthema (Rash) 07/2021 - 07/2004
2	Ductal Carcinoma 05/2020 - 04/2014
2	Left Ventricular Dysfunction 01/2020 - 01/2012
2	Cardiotoxicity 04/2019 - 04/2018
2	Leukopenia 01/2019 - 08/2017
2	Hypertension (High Blood Pressure) 06/2018 - 09/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2018 - 09/2013
2	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2018 - 01/2007
2	Carcinoma (Carcinomatosis) 01/2017 - 08/2004
2	Inflammatory Breast Neoplasms 06/2016 - 01/2012
2	Alopecia (Baldness) 10/2015 - 10/2014
2	Lymphatic Metastasis 10/2015 - 03/2015
2	Vomiting 09/2013 - 01/2007
2	Nausea 09/2013 - 01/2007
2	Esophageal Neoplasms (Esophageal Cancer) 10/2005 - 08/2004
2	Colorectal Neoplasms (Colorectal Cancer) 07/2005 - 04/2005
2	Hepatocellular Carcinoma (Hepatoma) 11/2004 - 03/2002

Drug/Important Bio-Agent (IBA)

26	Hormones (Hormone)IBA 11/2023 - 06/2011
24	Trastuzumab (Herceptin)FDA Link 12/2023 - 01/2011
19	human ERBB2 proteinIBA 10/2022 - 01/2011
17	ErbB Receptors (EGF Receptor)IBA 01/2024 - 04/2011
17	pertuzumabIBA 12/2023 - 01/2012
17	Docetaxel (Taxotere)FDA Link 12/2023 - 01/2007
14	taxaneIBA 10/2023 - 03/2009
12	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2011
12	Estrogen ReceptorsIBA 01/2021 - 08/2010
10	AnthracyclinesIBA 10/2022 - 08/2005
10	Capecitabine (Xeloda)FDA Link 01/2022 - 07/2005
10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2003
8	Fulvestrant (Faslodex)FDA Link 11/2023 - 09/2013
7	Ado-Trastuzumab EmtansineIBA 10/2022 - 10/2015
7	Progesterone Receptors (Progesterone Receptor)IBA 05/2020 - 10/2010
7	Lapatinib (GW572016)FDA Link 12/2019 - 01/2011
7	Gemcitabine FDA Link 01/2019 - 01/2004
7	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 11/2004
6	ParaffinIBA 01/2023 - 05/2005
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 05/2013
5	Epidermal Growth Factor (EGF)IBA 06/2023 - 12/2008
5	palbociclibIBA 06/2023 - 08/2017
5	Fluorouracil (Carac)FDA LinkGeneric 04/2009 - 04/2005
4	Letrozole (Femara)FDA LinkGeneric 06/2023 - 01/2018
4	Tumor Biomarkers (Tumor Markers)IBA 04/2023 - 01/2019
4	ribociclibIBA 03/2022 - 01/2018
4	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2016
4	Phenobarbital (Luminal)FDA Link 04/2019 - 01/2012
4	eribulin FDA Link 01/2019 - 04/2017
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017 - 04/2009
3	PlatinumIBA 01/2024 - 03/2009
3	Aromatase InhibitorsIBA 11/2023 - 09/2013
3	CytokinesIBA 10/2023 - 01/2020
3	Formaldehyde (Formol)FDA Link 01/2023 - 01/2013
3	Taxoids (Taxanes)IBA 10/2022 - 08/2005
3	exemestane (Aromasin)FDA Link 07/2021 - 09/2013
3	Vinorelbine (Navelbine)FDA LinkGeneric 12/2019 - 03/2016
3	orantinib (SU6668)IBA 12/2017 - 08/2014
3	Angiogenesis InhibitorsIBA 12/2017 - 08/2014
2	Cyclin-Dependent Kinase 4IBA 01/2024 - 01/2020
2	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 10/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 07/2017
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 02/2016
2	Tamoxifen FDA LinkGeneric 12/2019 - 11/2018
2	Anastrozole (Arimidex)FDA LinkGeneric 11/2018 - 09/2013
2	Messenger RNA (mRNA)IBA 02/2016 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 09/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016 - 04/2015
2	Matrix Metalloproteinases (MMPs)IBA 04/2011 - 12/2008
2	Proto-Oncogene Protein c-ets-1IBA 12/2008 - 07/2005
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2008 - 07/2005
2	Irinotecan (Camptosar)FDA LinkGeneric 07/2005 - 04/2005
2	Leucovorin (Folinic Acid)FDA Link 07/2005 - 04/2005
2	Etoposide (VP 16)FDA LinkGeneric 12/2003 - 11/2003
1	durvalumabIBA 01/2024

Therapy/Procedure

46	Therapeutics 01/2024 - 11/2003
35	Drug Therapy (Chemotherapy) 01/2024 - 01/2004
27	Neoadjuvant Therapy 10/2023 - 01/2007
12	Adjuvant Chemotherapy 01/2022 - 10/2005
9	Radiotherapy 10/2023 - 09/2012
6	Combination Drug Therapy (Combination Chemotherapy) 11/2017 - 01/2004
4	Segmental Mastectomy (Lumpectomy) 06/2018 - 03/2015
3	Salvage Therapy 10/2023 - 12/2013
3	Chemoradiotherapy 12/2005 - 12/2003
2	Immunotherapy 01/2023 - 07/2017
2	Palliative Care (Palliative Therapy) 01/2019 - 01/2013
2	Maintenance Chemotherapy 07/2015 - 05/2013